Literature DB >> 1803063

Differential sensitivity to physical dependence on morphine and codeine in three inbred strains of mice.

T Suzuki1, K Otani, M Misawa.   

Abstract

The purpose of this experiment is to investigate genetic differences in the development of physical dependence on morphine and codeine in inbred strains of mice, C57BL/6, C3H/He and DBA/2. Mice were treated with morphine- or codeine-admixed food (1, 2 and 3 mg/g of food) for 3 to 9 days. After the termination of drug treatment, the mice were given naloxone (5 mg/kg, s.c.). The incidences of jumping and teeth chattering by naloxone challenge in morphine- and codeine-treated C57BL/6 mice were much greater than those in C3H/He and DBA/2 mice. However, the incidences of other naloxone-precipitated withdrawal signs, such as ptosis and diarrhea, were not different among the three inbred strains of mice. These results indicate that genotype is an important determinant of the degree of most naloxone-precipitated withdrawal signs in morphine- and codeine-treated mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1803063     DOI: 10.1254/jjp.57.455

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Codeine containing cough syrup addiction in assam and nagaland.

Authors:  N S Wairagkar; J Das; S Kumar; J Mahanta; K Satyanarayana; R K Phukan; M Chetia; S K Goswami
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

2.  Analysis of candidate genes for morphine preference quantitative trait locus Mop2.

Authors:  G A Doyle; C L Schwebel; S E Ruiz; A D Chou; A T Lai; M-J Wang; G G Smith; R J Buono; W H Berrettini; T N Ferraro
Journal:  Neuroscience       Date:  2014-07-22       Impact factor: 3.590

3.  A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence.

Authors:  Gad Klein; Aaron Juni; Amanda R Waxman; Caroline A Arout; Charles E Inturrisi; Benjamin Kest
Journal:  Pharmacol Biochem Behav       Date:  2008-04-04       Impact factor: 3.533

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.